ArticleAIDS research and therapy2024

Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university.

Bridget Atuhaire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.